There have been significant supply chain challenges across the world since 2021. Every good and service supplier seems to have been impacted by the current supply chain crisis, whether it’s lumber, car parts, or grocery deliveries.1 That includes suppliers to the biopharmaceutical industry, like Cytiva, which offers both instruments and consumables for bioprocessing.
A key consumable in downstream bioprocessing, the chromatography resin, is one material that has been impacted by increased demand. However, as a long-term industry stalwart supplier of resins, Cytiva is dedicated to ensuring not only the highest quality resin product but also security of supply. At Cytiva, the Security of Supply team helps ensure that manufacturers can rely on us to get the resins they need to fill their drug development and manufacturing pipeline when they need them.
In this article, we provide an overview of the resin manufacturing process and describe how Cytiva is helping alleviate supply chain issues through its reliable product discontinuation policy, commitment to business continuity management (BCM), and capacity expansion plans.